CapVest Is Said to Near €10 Billion Deal for Drugmaker Stada

Aug. 31, 2025, 9:57 PM UTC

CapVest Partners is nearing a deal to acquire Stada Arzneimittel AG for around €10 billion ($11.7 billion) including debt, potentially ending the long-running saga to sell the German drugmaker, according to people familiar with the matter.

The London-based buyout firm is finalizing terms of an agreement with Stada’s private equity owners Bain Capital and Cinven, the people said. They could announce a deal as soon as Monday if there aren’t any last-minute hiccups, according to the people, who asked not to be identified because the information is private.

Discussions had earlier hit an impasse amid disagreements over valuation, the ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.